SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 8th, 2024 • Rallybio Corp • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 10, 2024, by and among Rallybio Corporation, a Delaware corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 8th, 2024 • Rallybio Corp • Pharmaceutical preparations
Contract Type FiledAugust 8th, 2024 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of April 10, 2024, by and among Rallybio Corporation, a Delaware corporation (the “Company”), and the purchaser signatory hereto (the “Purchaser”).
FNAIT COLLABORATIONAGREEMENTFnait Collaboration Agreement • August 8th, 2024 • Rallybio Corp • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2024 Company Industry JurisdictionThis FNAIT Collaboration Agreement (“Agreement”) by and between Momenta Pharmaceuticals, Inc. (“Company”), having a place of business at 1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States and Rallybio IPA, LLC (“Rallybio”), having a place of business at 234 Church Street, Suite 1020, New Haven, CT 06510, is made and effective as of the date of the last signature hereto (the “Effective Date”).